RUBY — Rubius Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $5.16m
- -$9.71m
- 18
- 50
- 59
- 38
Annual cashflow statement for Rubius Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -89.2 | -163 | -168 | -197 | -180 |
| Depreciation | |||||
| Non-Cash Items | 29.5 | 39.6 | 34.3 | 37 | 40.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.119 | 10.4 | 0.112 | 6.69 | -17.5 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -58.3 | -110 | -128 | -145 | -150 |
| Capital Expenditures | -15 | -40.7 | -5.5 | -3.65 | -5.3 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -96.7 | -92 | 106 | 85 | 18.2 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -112 | -133 | 100 | 81.4 | 12.9 |
| Financing Cash Flow Items | -3.83 | 0 | 0 | -0.51 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 375 | 27.3 | 26.5 | 198 | -75.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 205 | -216 | -0.732 | 135 | -213 |